Jnana Therapeutics
Frank Wu is a Senior Director at Jnana Therapeutics with extensive experience in process chemistry and CMC. Prior to their current role, Frank held various positions at Entasis Therapeutics, AstraZeneca, Sunovion Pharmaceuticals Inc., Enanta Pharmaceuticals, and Sepracor. Frank completed their postdoctoral fellowship at Harvard University and holds a Ph.D. from the University of Rochester in synthetic chemistry. Frank also has an MS in inorganic/organometallic chemistry from Fudan University and a BS in organic chemistry from Zhengzhou University.
Jnana Therapeutics
1 followers
Jnana is building the first drug discovery platform dedicated to SLC transporters. This proprietary chemistry and biology platform allows the company to rapidly and comprehensively address therapeutic targets across the greater the 400-member membrane protein family